Patrick O'Donnell

ProChon Biotech, Ltd. manufactures innovative growth factor-based therapies in regenerative medicine and orthopedics. The company was founded by Avner Yayon in 1995 and is headquartered in Tel Aviv, Israel.

Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.

ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA.

Confluent Surgical, Inc. designed and developed medical devices. The company was founded by Farhad Khosravi in August 1998 and was headquartered in Waltham, MA.

NanoHive Medical LLC is a leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company is based in Woburn, MA. The company's proprietary biomimetic Soft Titanium™ technology sets them apart in the $1.50B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration, all of which lead to consistently strong fusion constructs and efficacious clinical experiences. NanoHive was founded by Chris Jones and Ian Helmar, and the CEO is Patrick T. O'Donnell.